Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first ...

The body’s pathogen fighters can act as surveillance forces that ferry information from the gut and fat deposits to the brain ...

Groundbreaking study reveals TR1 cells' crucial role in immune response to malaria, paving way for new vaccines and drugs.

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first ...

As the global population ages, age-related diseases such as cardiovascular disorders, neurodegeneration, type 2 diabetes, and ...

This opening article in our miniseries examines the importance of the gut microbiome and its role in influencing cancer risk.

Immutep’s efti with radiotherapy and pembrolizumab meets primary endpoint in phase II trials for soft tissue sarcoma ...